ELEVATED LDL-C

Clinical trials for ELEVATED LDL-C explained in plain language.

Never miss a new study

Get alerted when new ELEVATED LDL-C trials appear

Sign up with your email to follow new studies for ELEVATED LDL-C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New gene-silencing drug aims to lower bad cholesterol without permanent DNA changes

Disease control Not yet recruiting

This early-stage study tests STX-1150, a new medicine that temporarily turns off a gene (PCSK9) in the liver to lower bad cholesterol (LDL-C). It does not change your DNA. Up to 64 adults with high LDL-C will receive one or more doses and be followed for a year. The main goal is …

Matched conditions: ELEVATED LDL-C

Phase: PHASE1 • Sponsor: Monash University • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC

ELEVATED LDL-C

Get alerted when new ELEVATED LDL-C trials appear

New gene-silencing drug aims to lower bad cholesterol without permanent DNA changes